Myrica offers an extensive product portfolio for a wide range of therapeutic purposes such as for pain and palliative care, infections, women’s healthcare, cardiovascular conditions and diabetes.
With a strong product development and a well-filled product pipeline, Myrica ensures a continuous flow of product launches and therefore also the continuous expansion of the existing product portfolio – particularly in the Branded and Generic segment.
In addition to low-cost, high-quality products, we market a comprehensive, diverse and highly complementary portfolio of specialty and generic products targeting a wide spectrum of chronic and acute treatments. We remain committed to providing affordable medicines of global quality standards to patients all over the world.
Therapeutic Segments
- Anti-infectives
- Analgesics, and Antipyretics
- Corticosteriods
- Anti-inflammatory
- Multi-vitamins
- Gastrointestinal
- Cough and cold preparations
